Chen Sheng-Hsuan, Lin Kai-Yuan, Chang Chun-Chao, Fang Chia-Lang, Lin Chih-Ping
Division of Gastroenterology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Food Chem Toxicol. 2007 Nov;45(11):2296-303. doi: 10.1016/j.fct.2007.06.005. Epub 2007 Jun 12.
The purpose of this study was to investigate the anticancer effect of aloe-emodin, an anthraquinone compound present in the leaves of Aloe vera, on two distinct human gastric carcinoma cell lines, AGS and NCI-N87. We demonstrate that aloe-emodin induced cell death in a dose- and time-dependent manner. Noteworthy is that the AGS cells were generally more sensitive than the NCI-N87 cells. Aloe-emodin caused the release of apoptosis-inducing factor and cytochrome c from mitochondria, followed by the activation of caspase-3, leading to nuclear shrinkage and apoptosis. In addition, exposure to aloe-emodin suppressed the casein kinase II activity in a time-dependent manner and was accompanied by a reduced phosphorylation of Bid, a downstream substrate of casein kinase II and a pro-apoptotic molecule. These preclinical studies suggest that aloe-emodin represents a suitable and novel chemotherapeutic drug candidate for the treatment of human gastric carcinoma.
本研究的目的是调查芦荟大黄素(一种存在于库拉索芦荟叶片中的蒽醌化合物)对两种不同的人胃癌细胞系AGS和NCI-N87的抗癌作用。我们证明芦荟大黄素以剂量和时间依赖性方式诱导细胞死亡。值得注意的是,AGS细胞通常比NCI-N87细胞更敏感。芦荟大黄素导致凋亡诱导因子和细胞色素c从线粒体释放,随后激活caspase-3,导致细胞核收缩和凋亡。此外,暴露于芦荟大黄素以时间依赖性方式抑制酪蛋白激酶II活性,并伴随着酪蛋白激酶II的下游底物和促凋亡分子Bid磷酸化的减少。这些临床前研究表明,芦荟大黄素是一种适用于治疗人胃癌的新型化疗药物候选物。